Lifecome Biochemistry Co

Lifecome Biochemistry Co Net Margin

The Net Profit Margin of Lifecome Biochemistry Co (002868.SZ) as of Oct 29, 2026 is -26.96 %. In the previous year, Net Profit Margin was -68.51 % — a change of -60.65% (higher).

Net Margin

-26.96 %

YoY

-60.65%

Last updated:

Net Profit Margin of Lifecome Biochemistry Co is 2025 -26.96 % . Net Profit Margin of Lifecome Biochemistry Co was 2024 -68.51 % . It decreases by -60.65% higher compared to the previous year.

Lifecome Biochemistry Co's net margin stands at -27.0%, down from -7.2% several years earlier.

The Lifecome Biochemistry Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
21.69 CNY
Jan 1, 2019
18.75 CNY
Jan 1, 2020
14.02 CNY
Jan 1, 2021
-7.17 CNY
Jan 1, 2022
-36.97 CNY
Jan 1, 2023
-43.75 CNY
Jan 1, 2024
-68.51 CNY
Jan 1, 2025
-26.96 CNY
The Lifecome Biochemistry Co Net Margin history
YEARNet MarginYoY
-26.96 %-60.65%
-68.51 %+56.58%
-43.75 %+18.35%
-36.97 %+415.80%
-7.17 %-151.11%
14.02 %-25.23%
18.75 %-13.55%
21.69 %-5.22%
22.89 %-0.51%
23.00 %+13.58%
20.25 %+90.49%
10.63 %+9,483.04%
0.11 %-21.34%
0.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Lifecome Biochemistry Co Stock analysis

What does Lifecome Biochemistry Co do? Lifecome Biochemistry Co., Ltd. generates revenue through the production and sale of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives, and biological pesticides. The company's product portfolio includes bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series, and Jinggangmycin series. These products are distributed domestically and internationally, targeting agricultural and veterinary sectors for animal health and feed enhancement. The firm's primary customers are domestic agricultural enterprises and international buyers seeking veterinary and feed solutions. Veterinary premixes and raw materials are key revenue drivers, alongside biological pesticides used in farming. Food and feed additives cater to the growing demand for safe and efficient animal nutrition products in both local and global markets. Lifecome Biochemistry's sales strategy focuses on leveraging its range of microbial pharmaceuticals, including probiotics and biological pesticides, to serve the agricultural industry. The company's domestic market presence is complemented by overseas distribution, ensuring a steady revenue stream from both regional and international clients. Lifecome Biochemistry Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifecome Biochemistry Co stock

Net Profit Margin of Lifecome Biochemistry Co is -26.96 % in 2025.

Net Profit Margin of Lifecome Biochemistry Co changed from -68.51 % to -26.96 %, representing a -60.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Lifecome Biochemistry Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Lifecome Biochemistry Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Lifecome Biochemistry Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Lifecome Biochemistry Co